Cargando…

Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study

BACKGROUND: China incurs an extremely low treatment coverage of multidrug-resistant tuberculosis (MDR-TB). This study aimed to understand the experience of MDR-TB patients on quality of health care, and the clinical impact through an up to six-year follow-up. METHODS: Cohorts of MDR-TB patients were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Xu-Bin, Diwan, Vinod K., Zhao, Qi, Hu, Yi, Bruchfeld, Judith, Jiang, Wei-Li, Hoffner, Sven, Xu, Biao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368741/ https://www.ncbi.nlm.nih.gov/pubmed/32682446 http://dx.doi.org/10.1186/s40249-020-00719-x

Ejemplares similares

Rising challenge of multidrug-resistant tuberculosis in China: a predictive study using Markov modeling
por: Li, Bing-Ying, et al.
Publicado: (2020)

Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatment
por: Hu, Yi, et al.
Publicado: (2016)

Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study
por: Davies Forsman, Lina, et al.
Publicado: (2018)

Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: A molecular epidemiological study
por: Hu, Yi, et al.
Publicado: (2010)

Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China
por: Zheng, Xubin, et al.
Publicado: (2022)

High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis
por: Yang, Zhiqi, et al.
Publicado: (2018)

Comparison between RFLP and MIRU-VNTR Genotyping of Mycobacterium tuberculosis Strains Isolated in Stockholm 2009 to 2011
por: Jonsson, Jerker, et al.
Publicado: (2014)

Drug Resistant Mycobacterium tuberculosis of the Beijing Genotype Does Not Spread in Sweden
por: Ghebremichael, Solomon, et al.
Publicado: (2010)

The Epidemiological Significance and Temporal Stability of Mycobacterial Interspersed Repetitive Units-Variable Number of Tandem Repeats-Based Method Applied to Mycobacterium tuberculosis in China
por: Li, Yang, et al.
Publicado: (2018)

Experiences in anti-tuberculosis treatment in patients with multiple previous treatments and its impact on drug resistant tuberculosis epidemics
por: Xu, Biao, et al.
Publicado: (2014)

Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis
por: Zhang, Haoyue, et al.
Publicado: (2023)

Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Multi-Ethnic Region, Xinjiang Uygur Autonomous Region, China
por: Qi, Ying-Cheng, et al.
Publicado: (2012)

Identification and attribute analysis of key stakeholders who influence multidrug-resistant tuberculosis prevention and control in China
por: Chen, Bin, et al.
Publicado: (2021)

Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients
por: Shao, Ge, et al.
Publicado: (2023)

Extensive global movement of multidrug-resistant M. tuberculosis strains revealed by whole-genome analysis
por: Cohen, Keira A, et al.
Publicado: (2019)

Fever in Children - an Assessment of Validity by a Shewhart Model in a Syndromic Surveillance System in China
por: Zhou, Changming, et al.
Publicado: (2015)

Genomic Stability over 9 Years of an Isoniazid Resistant Mycobacterium tuberculosis Outbreak Strain in Sweden
por: Sandegren, Linus, et al.
Publicado: (2011)

High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India
por: D'souza, Desiree TB, et al.
Publicado: (2009)

Applying Zero-inflated Mixed Model to School Absenteeism Surveillance in Rural China
por: Song, Xiaoxiao, et al.
Publicado: (2013)

Increased risk of active tuberculosis during pregnancy and postpartum: a register-based cohort study in Sweden
por: Jonsson, Jerker, et al.
Publicado: (2020)

Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China
por: Li, Yang, et al.
Publicado: (2019)

Distinguishing Nontuberculous Mycobacteria from Multidrug-Resistant Mycobacterium tuberculosis, China
por: Xu, Kaijin, et al.
Publicado: (2014)

Prevalence of Multidrug-Resistant Tuberculosis in Dalian, China: A Retrospective Study
por: Du, Liang, et al.
Publicado: (2021)

Cost-effectiveness of the latent tuberculosis screening program for migrants in Stockholm Region
por: Shedrawy, Jad, et al.
Publicado: (2021)

The Growth and Variation of Symptoms of Influenzalike Illness: An Application of the Linear Growth Curve Model in Syndromic Surveillance in Rural China
por: Song, Xiaoxiao, et al.
Publicado: (2014)

Adverse Events Associated with Treatment of Multidrug-Resistant Tuberculosis in China: An Ambispective Cohort Study
por: Zhang, Yang, et al.
Publicado: (2017)

Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study
por: Wang, Jianjie, et al.
Publicado: (2020)

Treatment outcomes of patients with multidrug and extensively drug-resistant tuberculosis in Zhejiang, China
por: Zhang, Ming-Wu, et al.
Publicado: (2021)

Epidemiological characteristics and risk factors of multidrug-resistant tuberculosis in Luoyang, China
por: Wang, Zhenzhen, et al.
Publicado: (2023)

Quality of life of patients on treatment for latent tuberculosis infection: a mixed-method study in Stockholm, Sweden
por: Shedrawy, Jad, et al.
Publicado: (2019)

Treatment Outcomes and Risk Factors of Multidrug-Resistant Tuberculosis Patients in Xi’an China, a Retrospective Cohort Study
por: Ma, Jin-Bao, et al.
Publicado: (2022)

Multidrug-Resistant Tuberculosis, People’s Republic of China, 2007–2009
por: He, Guang Xue, et al.
Publicado: (2011)

Using Medications Sales from Retail Pharmacies for Syndromic Surveillance in Rural China
por: Yan, Weirong, et al.
Publicado: (2013)

Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain
por: Eldholm, Vegard, et al.
Publicado: (2015)

Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four?
por: Grard, Soazic, et al.
Publicado: (2015)

Performance of Four Transport and Storage Systems for Molecular Detection of Multidrug-Resistant Tuberculosis
por: Rabodoarivelo, Marie Sylvianne, et al.
Publicado: (2015)

Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China
por: Zhao, Jiang-nan, et al.
Publicado: (2015)

Beijing strains of Mycobacterium tuberculosis in smear-positive tuberculosis patients in North-West and West of Iran
por: Sahebi, Leyla, et al.
Publicado: (2016)

Practical Experiences of Delivering Multidrug-Resistant Tuberculosis Comprehensive Supportive Care Services in China
por: Ruan, Yunzhou, et al.
Publicado: (2021)

Village Doctors’ Acceptability to a Syndromic Surveillance System in Rural China
por: Fei, Yang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fpbi35936utb1eura0s8tl72i6